India Pharma sales to rise to $27 bn in 2016- Deloitte

India Pharma sales to rise to $27 bn in 2016- Deloitte

…exclusivity rights, can be issued for some of them to bring down healthcare costs and boost access to drugs to treat diseases such as cancer, HIV/AIDS and hepatitis. The US and its pharma lobby has been…

5
Like
Save

Comments

Write a comment

*